A PROSPECTIVE PHASE II STUDY OF INGUINAL NODE SPARING RADIOTHERAPY FOR PATIENTS WITH EARLY STAGE ANAL CANCER (INSPIRE)

Registry ID

IIT-0021

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

CROSS CANCER INSTITUTE - CANCER CARE ALBERTA

Start date

2025-04-24

Last update

2022-05-05

Conditions

• ANAL CANCER

Related clinical trials

• A RANDOMIZED PHASE II STUDY OF NIVOLUMAB AFTER COMBINED MODALITY THERAPY (CMT) IN HIGH-RISK ANAL CANCER

View on source registry